Warfarin Trumps Platelet Agents in Atrial Fibrilation
/
RSS Feed
For atrial fibrillation, oral anti-coagulation remains the treatment of choice despite the potential of an anti-platelet regimen based on aspirin and clopidogrel, according to the ACTIVE-W trial. Stuart Connolly from McMaster University presented the findings.
[audio:https://www.audiomedica.com/podcasting/aha2005/Stuart_Connolly.mp3]
You may also like...
Torcetrapib in Patients at High Risk for Coronary Events: ILLUMINATE Trial Latest Results 6 Nov, 2007 - Increased Use of Recommended Drugs Explains Improved Trends in Prognosis after Myocardial Infarction 26 Mar, 2007
- Angiotensin AT2 Receptor Agonist: Restorative Role For Patients With Hypertension? 29 Jun, 2009
- Never Too Old For Hypertension Treatment! 8 Apr, 2008
